All rights reservedMiddleton, Sandy2025-10-1720121747-493010.1111/j.1747-4949.2012.00774.xhttps://hdl.handle.net/20.500.14802/17677The Quality in Acute Stroke Care (QASC) was a cluster randomised control trial (CRCT) which evaluated the effectiveness of evidence-based clinical treatment protocols for the management of fever, hyperglycaemia and swallowing, in conjunction with multidisciplinary team building workshops, and a standardised interactive staff education program (collectively known as the Fever, Sugar, Swallowing (FeSS) intervention) to improve patient outcomes 90-days. We found that patients cared for in stroke units who received our intervention were 15.7% more likely to be alive and independent 90 days following their stroke. They also had significantly: fewer episodes of fever, lower mean temperatures, lower mean blood glucose levels, and better screening for swallowing difficulties.strokefeverhyperglycaemiaswallownursingleadingopinionJournal article2-s2.0-84858200417Controlled201011227